MA
VCYT icon

Montag & Associates’s Veracyte VCYT Stock Holding History

Montag & Associates’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.42K Hold
41
– – ﹤0.01% 856
2026
Q1 		$1.33K Buy
41
+6
+17% +$222 ﹤0.01% 878
2025
Q4 		$1.49K Sell
35
-4
-10% -$161 ﹤0.01% 892
2025
Q3 		$1.35K Buy
39
+3
+8% +$86 ﹤0.01% 971
2025
Q2 		$985 Hold
36
– – ﹤0.01% 913
2025
Q1 		$1.08K Buy
36
+4
+13% +$152 ﹤0.01% 944
2024
Q4 		$1.27K Hold
32
– – ﹤0.01% 926
2024
Q3 		$1.09K Hold
32
– – ﹤0.01% 971
2024
Q2 		$697 Hold
32
– – ﹤0.01% 959
2024
Q1 		$713 Buy
+32
New +$781 ﹤0.01% 954

Other funds holding VCYT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Montag & Associates's VCYT Position: Q2 2026 in Review

Montag & Associates held its Veracyte (VCYT) position steady in Q2 2026 at 41 shares worth $2.42K. The position accounts for ﹤0.01% of the portfolio, ranked #856.

Montag & Associates first reported a position in VCYT in Q1 2024 and has held it in 10 quarters since. 370 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.

  • Montag & Associates held 41 shares of Veracyte worth $2.42K as of Q2 2026.
  • Montag & Associates left its Veracyte share count unchanged in Q2 2026.
  • Veracyte made up ﹤0.01% of Montag & Associates's portfolio in Q2 2026, its #856 holding.
  • Montag & Associates first reported a position in Veracyte in Q1 2024 and has held it in 10 quarters since.
  • 370 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.

Based on Montag & Associates's 13F filing for Q2 2026, filed 5 Aug 2026.